DOWNLOAD

Agile GxP: Guidance on the use of agile in a GxP environment: Companion document

20 April 2019
Information Technology
Agile GxP: Guidance on the use of agile in a GxP environment: Companion document
296.18 KB
305 downloads

The BioPhorum IT Agile workstream has published a supplementary guide – Agile in GxP Environment: companion document, to be used alongside its original guidance ‘Guidance on the use of Agile in a GxP environment’ to provide more practical advice on how to implement agile in a GxP environment. The Companion is less about ‘what is Agile’ but more ‘how to do it’ in the biopharmaceutical arena.

Agile improves IT development by carrying out design changes with the customer—going through repeated iterations. This ensures that what is eventually delivered is actually what the customer needs, and with reduced errors after implementation.

What are the challenges?

The main challenges facing companies looking to adopt Agile are:

  • Perceived compliance risks
  • That benefits have not been clearly explained
  • There is no clear path to easily move to an Agile approach.

The impact of these issues include:

  • That the benefits of an Agile approach are not being delivered
  • IT systems may be developed inefficiently
  • IT teams often struggle to support increasing and constant business, process and organizational change
  • Compliance requirements may be seen as blockers, not

What does the Companion deliver?

The Companion is less about ‘what is Agile’ but more ‘how to do it’ in the biopharma arena. It also emphasizes the importance of a clear roadmap. “When you are thinking about making a change, a couple of things you have to understand are ‘where am I now?’ and ‘where do I want to be?’” explained BioPhorum Facilitator Jonathan Dakin. “So, the Companion illustrates the journey to a fuller implementation that is appropriate for the organization.”

The Companion roadmap details five levels to full Agile working that will help companies determine what level they are currently at and what they need to do to progress to the next stage. This approach will help companies understand how to implement Agile in GxP environments more rapidly and effectively.

The Companion will help deliver the following benefits:

  • Remove the barriers to Agile adoption
  • Provide clarity on the benefits of Agile
  • Clearly explain how to move to an Agile approach and how it forms part of an organization’s digital journey
  • Deliver better quality products that meet customer needs earlier than traditional development routes.

When delivering the Companion, the Agile workstream was successful because of the proactive and trusting collaboration with companies, using real-life examples in the document and by differentiating Agile in GxP for biopharma.

Lori Otto from Information Quality Services at Eli Lilly, who co-authored the Companion, believed that it was a vital step to Agile adoption. She said, “I hope the Companion will provide you with valuable information to help your company develop a roadmap to move forward in your Agile endeavors.”

The BioPhorum effect

Most of the workstream members who produced the initial Guidance remained on the team to develop the Companion and ensure a consistent approach. Some new companies—at different stages on the path to Agile implementation—also joined the team to bring new perspectives to discussions.

Otto explained that it was an “excellent experience being part of the BioPhorum team and meeting other pharma companies who are on a similar journey with adopting Agile in a GxP environment.”

Matthew McMenamin, Manager, Systems & Tech at GSK, added, “Working with the team on the generation of this guide was an outstanding experience. Not only does it provide an excellent roadmap through the Agile for GxP realm, I also learned a great deal through benchmarking with my peers and avoiding pitfalls through their lessons.”

Cogs On Dark Blue Background
NEWS
What do your key players need from IT systems in your CGT processes?
Buildings And Digital Clouds
NEWS
Electronic data exchange – the foundation for an efficient, resilient inbound supply chain
Digital arrow, blue
NEWS
Where to start with your biomanufacturing digital transformation
NEWS
BioPhorum’s vision for standardizing the traceability of CGTs

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing